You are currently viewing a new version of our website. To view the old version click .

Cancers, Volume 13, Issue 19

October-1 2021 - 300 articles

Cover Story: Magnetic resonance fingerprinting (MRF) is a relatively new framework for generating multiple quantitative magnetic resonance maps in a time-efficient manner. This review summarizes published studies on the detection and characterization of tumors using MRF. It also explores the use of MRF for radiotherapy planning. Currently, MRF still faces limitations such as limited motion robustness and prolonged post-processing time. However, with advances in technology, some of these limitations might be resolved through integration with deep learning and other novel AI techniques. The purpose of this review is to present the huge potential of MRF with a focus on oncological applications and make researchers in this area aware that this field is suitable for further studies. View this paper.
  • Issues are regarded as officially published after their release is announced to the table of contents alert mailing list .
  • You may sign up for email alerts to receive table of contents of newly released issues.
  • PDF is the official format for papers published in both, html and pdf forms. To view the papers in pdf format, click on the "PDF Full-text" link, and use the free Adobe Reader to open them.

Articles (300)

  • Article
  • Open Access
10 Citations
3,425 Views
17 Pages

Aberrant Signaling Pathways in Sinonasal Intestinal-Type Adenocarcinoma

  • Cristina Riobello,
  • Paula Sánchez-Fernández,
  • Virginia N. Cabal,
  • Rocío García-Marín,
  • Laura Suárez-Fernández,
  • Blanca Vivanco,
  • Verónica Blanco-Lorenzo,
  • César Álvarez Marcos,
  • Fernando López and
  • José Luis Llorente
  • + 1 author

7 October 2021

Sinonasal intestinal-type adenocarcinoma (ITAC) is strongly related to occupational exposure to wood and leather dust, however, little is known on the genetic alterations involved in tumor development and progression. The aim of this study was to ide...

  • Article
  • Open Access
32 Citations
6,000 Views
15 Pages

MET Amplification in Non-Small Cell Lung Cancer (NSCLC)—A Consecutive Evaluation Using Next-Generation Sequencing (NGS) in a Real-World Setting

  • Christoph Schubart,
  • Robert Stöhr,
  • Lars Tögel,
  • Florian Fuchs,
  • Horia Sirbu,
  • Gerhard Seitz,
  • Ruth Seggewiss-Bernhardt,
  • Rumo Leistner,
  • William Sterlacci and
  • Michael Vieth
  • + 7 authors

7 October 2021

In non-small cell lung cancer (NSCLC), approximately 1–3% of cases harbor an increased gene copy number (GCN) of the MET gene. This alteration can be due to de novo amplification of the MET gene or can represent a secondary resistance mechanism in re...

  • Article
  • Open Access
5 Citations
3,272 Views
18 Pages

RAS Mediates BET Inhibitor-Endued Repression of Lymphoma Migration and Prognosticates a Novel Proteomics-Based Subgroup of DLBCL through Its Negative Regulator IQGAP3

  • Chih-Cheng Chen,
  • Chia-Chen Hsu,
  • Sung-Lin Chen,
  • Po-Han Lin,
  • Ju-Pei Chen,
  • Yi-Ru Pan,
  • Cih-En Huang,
  • Ying-Ju Chen,
  • Yi-Yang Chen and
  • Yu-Ying Wu
  • + 1 author

7 October 2021

Phenotypic heterogeneity and molecular diversity make diffuse large B-cell lymphoma (DLBCL) a challenging disease. We recently illustrated that amoeboid movement plays an indispensable role in DLBCL dissemination and inadvertently identified that the...

  • Article
  • Open Access
15 Citations
3,686 Views
20 Pages

The RXR Agonist MSU42011 Is Effective for the Treatment of Preclinical HER2+ Breast Cancer and Kras-Driven Lung Cancer

  • Ana S. Leal,
  • Jessica A. Moerland,
  • Di Zhang,
  • Sarah Carapellucci,
  • Beth Lockwood,
  • Teresa Krieger-Burke,
  • Bilal Aleiwi,
  • Edmund Ellsworth and
  • Karen T. Liby

6 October 2021

(1) Background: Notwithstanding numerous therapeutic advances, 176,000 deaths from breast and lung cancers will occur in the United States in 2021 alone. The tumor microenvironment and its modulation by drugs have gained increasing attention and rele...

  • Article
  • Open Access
5 Citations
2,357 Views
10 Pages

Enhanced Delivery of Thermoresponsive Polymer-Based Medicine into Tumors by Using Heat Produced from Gold Nanorods Irradiated with Near-Infrared Light

  • Kohei Sano,
  • Yumi Ishida,
  • Toshie Tanaka,
  • Tatsuya Mizukami,
  • Tomono Nagayama,
  • Yoshie Haratake,
  • Masayuki Munekane,
  • Toshihide Yamasaki and
  • Takahiro Mukai

6 October 2021

The aim of this study was to establish a drug delivery system (DDS) for marked therapy of tumors using a thermoresponsive polymer, polyoxazoline (POZ). The effectiveness of the following was investigated: (i) the delivery of gold nanorods (GNRs) to t...

  • Article
  • Open Access
11 Citations
4,344 Views
20 Pages

6 October 2021

Pancreatic ductal adenocarcinoma (PDAC) is a highly aggressive tumor type with low patient survival due to the low efficacy of current treatment options. Cancer-associated fibroblasts (CAFs) in the tumor microenvironment (TME) create a dense fibrotic...

  • Article
  • Open Access
4 Citations
2,950 Views
13 Pages

Level of Combined Estrogen and Progesterone Receptor Expression Determines the Eligibility for Adjuvant Endocrine Therapy in Breast Cancer Patients

  • Jee Hyun Ahn,
  • Soon Bo Choi,
  • Jung Min Park,
  • Jee Ye Kim,
  • Hyung Seok Park,
  • Seung Il Kim,
  • Byeong-Woo Park and
  • Seho Park

6 October 2021

Hormone receptor (HR)-positive breast cancer has a heterogeneous pattern according to the level of receptor expression. Patients whose breast cancers express low levels of estrogen receptor (ER) or progesterone receptor (PgR) may be eligible for adju...

  • Article
  • Open Access
17 Citations
3,577 Views
18 Pages

Drug-Induced Resistance and Phenotypic Switch in Triple-Negative Breast Cancer Can Be Controlled via Resolution and Targeting of Individualized Signaling Signatures

  • Swetha Vasudevan,
  • Ibukun A. Adejumobi,
  • Heba Alkhatib,
  • Sangita Roy Chowdhury,
  • Shira Stefansky,
  • Ariel M. Rubinstein and
  • Nataly Kravchenko-Balasha

6 October 2021

Triple-negative breast cancer (TNBC) is an aggressive subgroup of breast cancers which is treated mainly with chemotherapy and radiotherapy. Epidermal growth factor receptor (EGFR) was considered to be frequently expressed in TNBC, and therefore was...

  • Article
  • Open Access
7 Citations
4,142 Views
19 Pages

BOLD Coupling between Lesioned and Healthy Brain Is Associated with Glioma Patients’ Recovery

  • Rafael Romero-Garcia,
  • Michael G. Hart,
  • Richard A. I. Bethlehem,
  • Ayan Mandal,
  • Moataz Assem,
  • Benedicto Crespo-Facorro,
  • Juan Manuel Gorriz,
  • G. A. Amos Burke,
  • Stephen J. Price and
  • Thomas Santarius
  • + 2 authors

6 October 2021

Predicting functional outcomes after surgery and early adjuvant treatment is difficult due to the complex, extended, interlocking brain networks that underpin cognition. The aim of this study was to test glioma functional interactions with the rest o...

  • Review
  • Open Access
6 Citations
5,235 Views
17 Pages

6 October 2021

Ovarian cancer is a heterogeneous disease affecting the aging ovary, in concert with a complex network of cells and signals, together representing the ovarian tumor microenvironment. As in the “Schrödinger’s cat” thought experiment, the context-depen...

of 30

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Cancers - ISSN 2072-6694